AMRX Stock-Based Compensation
Amneal Pharmaceuticals Inc Class A · Stock-Based Compensation
AMRX Stock-Based Compensation
Latest reported$26.81Mperiod ending
AMRX Stock-Based Comp ($0.00 → $26.81M)
Annual stock-based compensation
High-resolution chart · PNG
AMRX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 31,953,000 | |
| 27,768,000 | |
| 26,822,000 | |
| 31,847,000 | |
| 0 | |
| 20,750,000 | |
| 21,679,000 | |
| 167,597,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |